Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's Post-Market Leader Stock

26-11-2013 TheStreet.comComments (0)

PharmaceuticalVanda Pharmaceuticals

Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders. Currently there are 4 analysts that rate Vanda Pharmaceuticals a buy, no analysts rate ...

Read more on TheStreet.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top